PROTEKT 1999-2000: A multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan

International Journal of Infectious Diseases

Volumn 9, Issue 1, 2005, Pages 27-36

  Inoue, Matsuhisa ^a   Kohno, Shigeru ^b   Kaku, Mitsuo ^c   Yamaguchi, Keizo ^d   Igari, Jun ^e   Yamanaka, Kiyoharu ^f  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OTEMAE HOSPITAL   (Japan)

Author keywords

Antimicrobial susceptibility; Japan; Macrolide antibiotics; Respiratory pathogens

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; HAEMOPHILUS INFLUENZAE; HUMAN; JAPAN; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; RESISTANCE MANAGEMENT; RESPIRATORY SYSTEM; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; TIME SERIES ANALYSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 10444229544     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2004.03.008     Document Type: Article

References (29)

1. R. Dagan, K.P. Klugman, W.A. Craig, and F. Baquero Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy J Antimicrob Chemother 47 2001 129 140
2. D. Felmingham, and R.N. Grüneberg The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections J Antimicrob Chemother 45 2000 191 203
3. F. Baquero Pneumococcal resistance to β-lactam antibiotics: A global geographic overview Microb Drug Resist 1 1995 115 120
4. J.H. Song, N.Y. Lee, S. Ichiyama The Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study Clin Infect Dis 28 1999 1206 1211
5. J.A. Karlowsky, C. Thornsberry, and I.A. Critchley Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States Antimicrob Agents Chemother 47 2003 1790 1797
6. Y.Y. Hu, S.J. Yu, G. Liu, W. Gao, and Y.H. Yang Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000 Acta Paediatr 91 2002 136 140
7. R.N. Grüneberg, and D. Felmingham Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired, lower respiratory tract bacterial pathogens Diagn Microbiol Infect Dis 25 1996 169 181
8. L.A. Mandell Community-acquired pneumonia: Etiology, epidemiology and treatment Chest 108 1995 35S 42S
9. P. Ball Epidemiology and treatment of chronic bronchitis and its exacerbations Chest 108 1995 43S 52S
10. F. Goldstein, A. Bryskier, and P.C. Appelbaum The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral bacterial agents against respiratory pathogens Clin Microbiol Infect 4 1998 2S8 18
11. D. Felmingham Antibiotic resistance: Do we need new therapeutic approaches? Chest 108 1995 70S 78S
12. D.F. Sahm, M.E. Jones, M.L. Hickey, D.R. Diakun, S.V. Mani, and C. Thornsberry Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998 J Antimicrob Chemother 45 2000 457 466
13. D. Felmingham The need for antimicrobial resistance surveillance J Antimicrob Chemother 50 2002 1 7
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing - twelfth informational supplement M100-S12. NCCLS, Wayne, PA, USA, 2002.
15. D.J. Farrell, I. Morrissey, S. Bakker, and D. Felmingham Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid-cycle PCR with microwell-format probe hybridization J Antimicrob Chemother 48 2001 541 544
16. R.N. Jones The emergent needs for basic research, education and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antimicrobial Resistance Diagn Microbiol Infect Dis 25 1996 153 161
17. R. Yoshida, M. Kaku, and S. Kohno Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan Antimicrob Agents Chemother 39 1995 1196 1198
18. K.P. Klugman Pneumococcal resistance to antibiotics Clin Microb Rev 3 1990 171 196
19. J. Linares, T. Alonso, and J.L. Perez Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics J Antimicrob Chemother 30 1992 279 288
20. P. Trieu-Cuot, C. Poyart-Salmeron, C. Carlier, and P. Courvalin Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545 Nuc Acids Res 18 1990 3660 3666
21. J. Sutcliffe, A. Tait-Kamradt, and L. Wondrack Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system Antimicrob Agents Chemother 40 1998 1817 1824
22. A. Bryskier Novelties in the field of anti-infectives in 1997 Clin Infect Dis 2 1998 865 883
23. M-I. Morosini, R. Canton, and E. Loza In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms Antimicrob Agents Chemother 45 2001 2427 2431
24. K. Ohkusu, A. Nakamura, and K. Sawada Antibiotic resistance among recent clinical isolates of Haemophilus influenzae in Japanese children Diagn Microbiol Infect 36 2000 249 254
25. M.R. Jacobs, S. Bajaksouzian, A. Zilles, G. Lin, G.A. Pankuch, and P.C. Appelbaum Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study Antimicrob Agents Chemother 43 1999 1901 1908
26. K. Hasegawa, K. Yamamoto, and N. Chiba Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States Microb Drug Resist 9 2003 39 46
27. B.W. Catlin Branhamella catarrhalis: an organism gaining respect as a pathogen Clin Microbiol Rev 3 1990 293 320
28. J.H. Jorgensen, G.V. Doern, L.A. Maher, A.W. Howell, and J.S. Redding Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States Antimicrob Agents Chemother 34 1990 2075 2080
29. G.V. Doern, A.B. Bruggemann, G. Pierce, T. Hogan, H.P. Holley, and A. Rauch Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study Antimicrob Agents Chemother 40 1996 2884 2886